Q32 Bio Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Q32 Bio Inc. (FIXX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$13.36 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-12
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $2.18M.
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$58.92M, a 176.19% decline year-over-year.
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $48.75M.
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$5.36M, a 135.49% decline year-over-year.
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$13.36M, a 133.24% decline from fiscal 2017.
- Q32 Bio Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $40.18M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$56.74M derived: sum of 2 quarters · filed 2019-03-12 | -$7.99M derived: sum of 3 quarters · filed 2019-03-12 | -$13.36M 10-K · filed 2019-03-12 |
| 2018-09-30 | -$58.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$10.18M derived: sum of 2 quarters · filed 2018-11-13 | -$15.54M 10-Q · filed 2018-11-13 | -$61.73M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | $48.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $43.39M 10-Q · filed 2018-08-13 | -$2.81M derived: sum of 3 quarters · filed 2019-03-12 | $74.53M derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | -$5.36M 10-Q · filed 2018-05-14 | -$51.56M derived: sum of 2 quarters · filed 2019-03-12 | $25.78M derived: sum of 3 quarters · filed 2019-03-12 | $19.72M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | -$46.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $31.15M derived: sum of 2 quarters · filed 2019-03-12 | $25.08M derived: sum of 3 quarters · filed 2019-03-12 | $40.18M 10-K · filed 2019-03-12 |
| 2017-09-30 | $77.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $71.27M derived: sum of 2 quarters · filed 2018-11-13 | $86.38M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $9.04M 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $15.11M 10-Q · filed 2018-05-14 |